ABSTRACT
INTRODUCTION
Antiretroviral therapy (ART) for human immunodeficiency virus (HIV)-infected patients has improved survival while leading to increasing clinical interest in long-term morbidities in this population. Besides some adverse effects of ART 1 , patients are living longer, and new focus on aging diseases as cancer has emerged. Historically, Kaposi sarcoma (KS), non-Hodgkin lymphoma (NHL) and cervical cancer accounted for a substantial proportion of the morbidity and mortality in HIV-infected patients, and are considered acquired immunodeficiency syndrome (AIDS)-defining events 2 . These cancers are mainly caused by loss of immune control towards oncogenic viruses, specifically herpes virus, Epstein Barr virus and human papillomavirus, respectively. Compared with the general population, HIV-infected individuals are at increased risk for each of these diseases 3 , though the widespread use of ART since the mid-1990s led to a significant decline in the incidence of the KS and NHL 4, 5 . Besides better HIV control through ART, changes in human herpes virus-8 epidemiology may also explain the dramatic decline in number of KS cases 6 . However, despite an overall decline in cervical cancer incidence, numbers among women with AIDS are not declining 7 , although an ongoing, multicenter, prospective cohort of HIV-seropositive women and at-risk HIV-uninfected women in the United States (US) has shown that the incidence of invasive cervical cancer was not significantly higher in HIV-positive women when compared to the uninfected 8 
.
In the ART era, increased morbidity and mortality from several non-AIDS-defining malignancies (NADM) have also been reported in HIV-infected population 3, 9, 10 . A meta-analysis using standardized incidence ratios from 18 studies of NADM in HIV-infected people has shown that HIV-positive individuals had twice the risk of a NADM than the general population 11 . They also reported that the risk of NADM was greater among men and those with full-blown AIDS.
Several factors may contribute to the significant increase in NADM. The size of the HIV-infected population has increased in the last decades in the US from 1991-1995 to 2001-2005 7 . Furthermore, the incidence of most cancers increases with age, and there is a rising proportion of people with AIDS over 40 years of age nowadays. Cigarette smoking is also more common among HIV-infected individuals than the general population 12 and may contribute to the rising incidence of lung cancer. Moreover, immunodeficiency in the presence of other risk factors is responsible for the increased risk of NADM, which since 2003 exceeds the annual numbers of AIDS defining cancers in US 7 . However, there have been few reports of cancer and HIV in Brazil 13, 14, 15, 16 . Thus, the aim of this study was to report the prevalence of cancer and its associated factors among HIV-infected individuals attending an AIDS outpatient clinic in Vitória, State of Espírito Santo, Brazil.
METHODS
A sectional study was performed among adult HIV-1 infected patients (18 data including diagnostic of cancer, lethality, nadir and current cluster of differentation (CD4) cell count, HIV viral load, time on and type of ART and smoking (>20 cigars per day) were collected from all patients at time of cancer diagnosis. All cancer cases were confirmed by histological exams and followed by the oncologist.
Data were analyzed using Statistical Package for the Social Sciences (SPSS), version 17 for Windows (Chicago, IL, USA). Standard descriptive analyses were performed including frequency distributions for categorical data and calculation of medians and interquartile ranges for continuous variables. Univariate odds ratios and 95% confidence limits were reported. Variables that were significant at p<0.15 in bivariate analysis, and known confounders (e.g., age and gender), were considered in the multivariate model using a stepwise multiple logistic regression approach.
Ethical considerations
Prior to its implementation, the study protocol was submitted and approved by the Ethical Committee for Research of the Escola Superior de Ciências da Santa Casa de Misericórdia da Vitória, State of Espírito Santo.
A total of 730 (91.3%) cases were included in the study from the total of 800 patients attending the clinic in the period. The remaining 70 patients had missed their scheduled follow up consults during the study period, or were transferred to another clinic nearest to their residence. Median age was 44.0 [interquartile range (IQR): 35.0-50.3] years old, 441 (60%) were males and 430 (59%) were Caucasian. The median time since HIV diagnosis was 5.5 years (IQR: 2-10), 638 (87%) were on ART according to Brazilian guidelines and 478 (70%) patients had a HIV viral load below 50 copies/ml. Lethality was more frequent among cancer patients (23.3% x 1.9%, p<0,001).
The most frequently prescribed nucleoside reverse transcriptase inhibitor (NRTI) backbone was lamivudine-zidovudine, used by 350 (48%) patients followed by lamivudine-tenofovir used by 284 (39%). A total of 47% used boosted protease inhibitors followed by non-nucleoside reverse transcriptase inhibitors in 41% of patients. 
DISCUSSION
The authors declare that there is no conflict of interest. Cancers reported among HIV-infected patients in our AIDS outpatient clinic in Brazil were practically equally distributed between AIDS defining cancers and non-AIDS defining cancers. The distribution and nature of the samples as well as the study design (cross-sectional) were not the most suitable to make inferences about the cause and effect. However, as the response rate was high, the finding of this study can be generalizable to AIDS patients attending outpatient clinics for HIV in Brazil.
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Although in the ART era ADC rates are falling, these cancers still remain highly prevalent in HIV-infected patients. Despite decreases in mortality for AIDS-defining Cancers, NHL remains the most common cancer-related cause of death in the ART era 17 . HIV-infected women should be regularly screening for cervical cancer 7 . Several trials are ongoing to determine if human papilloma virus (HPV) vaccines are effective in HIV-infected men and women 18 , but the actual efficacy of the two currently available HPV vaccines has not yet been demonstrated among HIV young people.
Almost half of our cases of cancer were non-AIDS-defining malignancies. No significant difference was found when the two groups with cancer were compared perhaps because of the small number of cases. Two patients with liver cancer were hepatitis C virus (HCV) coinfected and two patients with Hodgkin lymphoma had mixed cellularity subtype (most common in HIV-infected patients). A study conducted in US showed that lung cancer, liver cancer, and Hodgkin lymphoma represented almost 50% of all NADM in the AIDS population compared with 16% of cancers in the general population 7 . Lung cancer is the third most common cancer among HIV-infected patients, following only ADC. Tobacco smoking explains part of this increased risk, but a study of a cohort of injection drug users in Baltimore supports HIV as an independent risk factor for lung cancer 19 . Hodgkin Lymphoma is around 10 times more frequent among HIV-infected people, especially among individuals with moderate immunosuppression 20 . Hepatocellular carcinoma, clearly linked to hepatitis C and hepatitis B co-infections among HIV-infected patients, was not frequently observed before the ART era because infected patients could not survive long enough to permit this clinical presentation 21 . A prospective observational cohort observed that the incidence of liver cancer was 7.7 fold higher in HIV-infected persons compared to the US general population 22 .
We found a higher chance of cancer with both nadir and current CD4 cell counts lower than 200, and heavy smoking habit was associated with both ADM and NADM. HIV-infected persons tend to smoke more heavily than HIV-negative persons 23 . In both the Concerted Action on Seroconversion to AIDS and Death in Europe (CASCADE) and the Data Collection on Adverse Events of Anti-HIV Drugs (DAD) cohorts, mortality from NADM also increased as CD4 cell count declined 24, 25 . Another prospective cohort reported that current CD4 cell count between 300 and 499 was the most predictive risk factor for all malignancies apart from anal cancer 26 . HIV-related cancers may decline with recent recommendations to initiate ART earlier following HIV diagnosis and at higher CD4 counts 27 . Our results showed that HIV patients with cancer present a worse prognosis and are dying earlier when compared to HIV patients without cancer. We emphasized the need to focus on several measures necessary to prevent cancer. First, we need to encourage patients to quit smoking. Psychology support, nicotine patches and available drugs would be necessary to assist those on need at the public network. As late-stage lung cancers have and extremely poor prognosis, screening for lung cancer in high risk individuals is necessary. A large randomized control trial compared the use of low-dose computed tomography (CT) scanning with chest radiographs and it was stopped earlier because of findings showing 20% less mortality benefit in the CT arm 28 . Vaccination for hepatitis B, alcohol use control and early treatment for hepatitis C are necessary to prevent liver cancer. Liver ultrasonography every 6-months (or at least yearly) is strongly advocated in groups at high risk for hepatocellular carcinoma 29 . Some controversy exists about the incidence of prostate and colorectal cancer in people with AIDS. Several reports 3,5�,21 suggest decreased risk for these cancers among HIV-infected people compared with the general population. However, Shiels et al observed a significant increase in incidence rates of prostate cancer in the HIV-infected population in the US 6 , which could reflect an increase in prostate cancer screening and an aging AIDS population in the ART era. All our three cases of prostate cancer were among men over 50 years of age.
Our finding highlights the importance of preventing and promptly treating cancer cases in AIDS patients. These patients must be screened annually for early detection of any kind of cancer to provide early treatment and follow-up due to the increasing rate of cancer in this population. 
